Chronic Kidney Disease (CKD) Market is set to witness a stable CAGR in the forecast period of 2019-2026

1
Chronic Kidney Disease (CKD) Market is set to
witness a stable CAGR in the forecast period of
2019-2026
Chronic Kidney Disease (CKD) Market By Therapy
Type (ACE inhibitors, Angiotensin II receptors
blockers, Calcium channel blockers, Beta
blockers, Diuretics others, Global chronic kidney
disease), Treatment (Medications, Kidney
transplantation and Dialysis), End- users
(Hospitals, Homecare, Specialty Clinics, Others),
Geography (North America, South America, Europe,
Asia-Pacific, Middle East and Africa) - Industry
Trends Forecast to 2026
Browse Full Report and Details TOC
https//www.databridgemarketresearch.com/toc/?dbm
rglobal-chronic-kidney-disease-ckd-market
2
Report Description
Global Chronic Kidney Disease (CKD) Market is
expected to rise gradually to an estimated value
of USD 19.02 billion by 2026, registering a CAGR
of 4.5 in the forecast period of 2019-2026 with
the annual sales of USD 13.38 billion in the year
2018. This rise in market value can be attributed
to the increasing awareness and concerns
regarding the health of patients. Chronic Kidney
disease (CKD) is a serious condition identified
by progressively loss of kidney function over a
time. CKD is not only treatable but also a major
contributing factor for death. CKD can be
classified into five stages from mild stage 1 to
complete kidney damage in stage 5. According to
the WHO, Global Burden of Disease (GBD) 2015, it
is estimated that more than 7.00 million patient
with chronic kidney disease died without
approaching any medication. This data shows lack
of awareness and poor availability of
intervention.
3
Major Key Players

• Some of the major players operating in this
  market are
• Pfizer Inc. (US)
• Amgen, Inc. (US)
• F. Hoffmann-La Roche Ltd (Switzerland)
• Abbott Laboratories (US)
• Bristol-Myers Squibb Company (US)
• GlaxoSmithKline Plc (UK)
• Novartis AG (Switzerland)
• Sanofi S.A (France)
• Teva Pharmaceutical Industries Ltd (Israel)

Inquire Before Buying https//www.databridgemark
etresearch.com/inquire-before-buying/?dbmrglobal-
chronic-kidney-disease-ckd-market
4
Market Segmentation

• By Type (ACE inhibitors, Angiotensin II receptors
  blockers, Calcium channel blockers, Beta
  blockers, Diuretics others, Global chronic kidney
  disease)
• By End-User ((Hospitals, Homecare, Specialty
  Clinics, Others)

Get Exclusive Sample Report _at_ https//www.databr
idgemarketresearch.com/request-a-sample/?dbmrglob
al-chronic-kidney-disease-ckd-market
5
Regional Analysis

• Based on geography, the market is segmented into
  five geographical regions
• North America
• Europe
• Asia-Pacific
• South America
• Middle East
• Africa

6
About Data Bridge Market Research
An absolute way to forecast what future holds is
to comprehend the trend today! Data Bridge Market
Research set forth itself as an unconventional
and neoteric Market research and consulting firm
with unparalleled level of resilience and
integrated approaches. We are determined to
unearth  the best market opportunities and foster
efficient information for your business to thrive
in the market. Data Bridge endeavors to provide
appropriate solutions to the complex business
challenges and initiates an effortless
decision-making process. Read Continue
http//databridgemarketresearch.com/about-us/
Contact Us Sopan Gedam Sopan.gedam_at_databridge
marketresearch.com